Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Impact of COVID-19 lockdown on progressive multiple sclerosis patients.
Vercellino M, Bosa C, Alteno A, Schillaci V, Petracca M, Marasciulo S, Cavalla P. Vercellino M, et al. Among authors: schillaci v. Neurol Sci. 2022 May;43(5):2943-2946. doi: 10.1007/s10072-022-05909-z. Epub 2022 Jan 24. Neurol Sci. 2022. PMID: 35075574 Free PMC article.
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context.
Sormani MP, Schiavetti I, Carmisciano L, Cordioli C, Filippi M, Radaelli M, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Cocco E, Scandellari C, Cavalla P, Pesci I, Zito A, Confalonieri P, Marfia GA, Perini P, Inglese M, Trojano M, Brescia Morra V, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; MuSC-19 Study Group. Sormani MP, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105. doi: 10.1212/NXI.0000000000001105. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34753829 Free PMC article.
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.
Sormani MP, Schiavetti I, Landi D, Carmisciano L, De Rossi N, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Brescia Morra V, Trojano M, Tedeschi G, Comi G, Battaglia MA, Patti F, Fragoso YD, Sen S, Siva A, Furlan R, Salvetti M; MuSC-19 Study Group. Sormani MP, et al. Mult Scler. 2022 Jun;28(7):1034-1040. doi: 10.1177/13524585211035318. Epub 2021 Jul 30. Mult Scler. 2022. PMID: 34328824
Fetal and post-natal growth in infants of mothers with multiple sclerosis: A case-control stud.
Marozio L, Cavalla P, Sottemano S, Vercellino M, Federici F, Cosma S, Peila C, Cresi F, Coscia A, Capobianco M, Bosa C, Schillaci V, Bellisario V, Migliaretti G, Benedetto C. Marozio L, et al. Among authors: schillaci v. Mult Scler Relat Disord. 2022 Sep;65:104087. doi: 10.1016/j.msard.2022.104087. Epub 2022 Aug 1. Mult Scler Relat Disord. 2022. PMID: 35933740
Dietary habits, nutritional status and risk of a first demyelinating event: an incident case-control study in a southern European cohort.
Cavalla P, Golzio P, Maietta D, Bosa C, Pasanisi MB, Alteno A, Schillaci V, Costantini G, Durelli P, Cuffini E, Panizzolo S, De Francesco A, Chiò A, Vercellino M. Cavalla P, et al. Among authors: schillaci v. Neurol Sci. 2022 Jul;43(7):4373-4380. doi: 10.1007/s10072-022-05908-0. Epub 2022 Feb 15. Neurol Sci. 2022. PMID: 35166977